Strategic Assessment of the Mitral And Aortic Valve (0.50)
Cardiology Grand Rounds 2021-22 (10 CME) • 33m
The Texas Heart Institute Cardiology Grand Rounds on March 11, 2022. Dr. Marc Moon. Strategic Assessment of the Mitral And Aortic Valve: A Surgeon's Perspective.
Course Materials: https://texasheart.org/Moon-3-2022
To Claim CME: https://www.surveymonkey.com/r/YK7SSKX
Please read all Course Materials before participating in this activity.
Course Materials
CME Information
Title of program: Cardiology Grand Rounds: Strategic Assessment of the Mitral and Aortic Valve: A Surgeon’s Perspective
Event# 9920
Date of Online Release: May 2, 2022
Date of Original Presentation: March 11, 2022
Credits: 0.50 AMA PRA Category 1 CreditsTM
Overview
Dr. Moon will explore the various pathoanatomic changes that occur in the mitral and aortic valve apparatus that can lead to regurgitation. Analysis of pathoanatomic alterations will then be used to determine the most efficient mechanistic approach to repair rather than replace regurgitant valves.
Educational Objectives
The intended result of this activity is increased knowledge. At the conclusion of this symposium, participants should be able to:
• Categorize three types of mitral valve pathology using the Carpentier classification
• Differentiate mode of aortic regurgitation caused by changes in the valve leaflets versus changes in the functional aortic annulus
• Describe techniques to repair the mitral and aortic valves
Target Audience
The intended audience for this continuing medical education activity includes physicians, faculty, fellows/residents and allied health.
Method of Instruction / Participation
This internet activity comprises slide sets with text and audio with post activity assessment and evaluation.
Evaluation / Feedback
We value your feedback; please send your suggestions and comments to the Office of Continuing Medical Education at Texas Heart Institute, [email protected].
Program Director
Stephanie Coulter, MD, FACC, FASE
Texas Heart Institute; Baylor St. Luke’s Medical Center
Houston, Texas
Acknowledgement of Support
This continuing medical education activity has been supported in part by educational grants from the following company: Edwards Lifesciences, LLC.
Accreditation / Credit Designation
Texas Heart Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Texas Heart Institute designates this enduring material for a maximum of 0.50 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Estimated Study Time
The estimated time to complete this activity, including review of the materials and completion of the course assessment is 30 minutes.
Repurposing Statement
If you previously completed and received credit for the live activity entitled, Cardiology Grand Rounds: Strategic Assessment of the Mitral and Aortic Valve: A Surgeon’s Perspective, on March 11, 2022, please note that you will not receive credit for completing this activity. Participants who take part in an identical activity, even in order to validate learning or to clarify specific topics, cannot claim, nor will the Texas Heart Institute award, duplicate credit for the activity.
Term of Approval
May 2, 2022 through May 2, 2024. Continuation of CME credit from May 2, 2024 depends upon a thorough review of the content for currency and accuracy.
Peer Review
On March 31, 2022 this continuing medical education activity was reviewed for currency and accuracy of content by Stephanie Coulter, MD, FACC, FASE; Director, Texas Heart Institute Center for Women’s Heart and Vascular Health; Associate Director, Non-Invasive Cardiology; Texas Heart Institute; Baylor St. Luke’s Medical Center; Cardiologist, Texas Heart Medical Group; Houston, Texas
Disclosure of Relationships
It is the intent of the Texas Heart Institute to ensure that its educational mission and its continuing medical activities in particular, should not be influenced by the special interests of individuals associated with its program.
Faculty Disclosure
In accordance with the guidelines of the Accreditation Council for Continuing Medical Education, faculty members have disclosed their relationships with either the manufacturers of commercial products discussed, or the corporate organizations offering educational grants for the live continuing medical education activity.
Marc R. Moon, MD is a member of the surgical advisory board for Medtronic.
The Planning Committee Members have nothing to disclose relevant to this program.
The THI CME Staff have nothing to disclose relevant to this program.
The Program Reviewers have nothing to disclose relevant to this program.
All relevant relationships have been mitigated.
Course Materials and CME Credit
This activity comprises of 1 presentation. By clicking on the Course Materials link, you acknowledge that you have reviewed the CME information provided above. After viewing the presentation, you must complete an assessment and evaluation to obtain CME credits for this activity.
By completing the Course Materials below, you acknowledge that you have reviewed the CME information provided above.
The video includes a Course Evaluation Survey and link to download your Certificate of Completion at the end.
Up Next in Cardiology Grand Rounds 2021-22 (10 CME)
-
Life Course of Cardiovascular Health ...
Texas Heart Institute Cardiology Grand Rounds on
March 18, 2022. Dr. Donald Lloyd-Jones. Life Course of Cardiovascular Health: Outcomes, Mechanisms, Correlates, and Determinants. -
Comprehensive Lifelong Expeditious Ao...
Texas Heart Institute Cardiology Grand Rounds on
April 1, 2022. Dr. Eric E. Roselli. Comprehensive Lifelong Expeditious Aortic Care Now and the Near Future -
Valve Disease, Anticoagulation, and P...
Texas Heart Institute Grand Rounds on May 27, 2022. Dr. Eric Krieger, There Ain't No Such Thing as a Free Lunch: Valve Disease, Anticoagulation and Pregnancy.